Pfannstiel et al. [42] conducted a study showing that high levels of TIL in bladder cancer were associated with increased expression of immune checkpoints such as PD-1 and PD-L1, tumor antigens, and mutational load, suggesting that bladder cancer patients with high infiltrating lymphocytes would benefit more from ICIs. The gene discussed is CD274; the disease is urinary bladder carcinoma.